BUSINESSWIRE · 2026-11-02 12:00 UTC

Caldera Therapeutics Appoints Michelle Doig as Chief Financial Officer and Lee Giguere as Chief Legal Officer

Caldera Therapeutics appoints Michelle Doig as CFO and Lee Giguere as CLO to strengthen leadership ahead of going public. The company is preparing to merge with Synlogic (OTC: SYBX) in an all-stock transaction and plans to trade on NYSE American under ticker 'CALD'. Caldera is advancing CLD-423, a bispecific antibody for inflammatory bowel disease, into Phase 2 trials.

Loading the story on Tree News…